Paper Details
- Home
- Paper Details
The controversy concerning plasma homocysteine in Parkinson disease patients treated with levodopa alone or with entacapone: effects of vitamin status.
Author: HauserRobert A, MerlinLisa R, SullivanKelly L, WeckerLynn, ZesiewiczTheresa A
Original Abstract of the Article :
Levodopa treatment of Parkinson disease results in hyperhomocysteinemia (HHcy) as a consequence of levodopa methylation by catechol-O-methyltransferase (COMT). Although inhibition of COMT should theoretically prevent or reduce levodopa-induced HHcy, results from several prospective studies are confl...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://pubmed.ncbi.nlm.nih.gov/16772808
データ提供:米国国立医学図書館(NLM)
The Desert of Parkinson's Disease: The Role of Homocysteine
The desert of Parkinson's disease, like a desolate landscape, presents a unique challenge for researchers. The study explores the intricate relationship between homocysteine, a molecule that plays a significant role in the desert of neurological health, and levodopa treatment for Parkinson's disease. Levodopa, a key medication for this condition, can inadvertently increase homocysteine levels, creating a complex interplay between treatment and the desert of neurological health. The researchers, like intrepid explorers, sought to understand the influence of vitamin status on homocysteine levels, as if uncovering hidden springs within the desert. Their findings, like a shimmering oasis in the midst of a harsh landscape, revealed a critical link between vitamin levels and the impact of levodopa treatment on homocysteine levels.
The Oasis of Vitamin Status: A Key to Balance
The study discovered that individuals with low folate levels were more susceptible to elevated homocysteine levels when taking levodopa. Conversely, individuals with adequate folate levels experienced less of an increase in homocysteine levels. These findings, like a well-defined trail through the desert, highlight the importance of vitamin status in managing homocysteine levels and potentially optimizing levodopa treatment for Parkinson's disease.
The Journey Towards Balance: Navigating the Desert
This study underscores the importance of maintaining adequate vitamin levels, particularly folate, in individuals taking levodopa for Parkinson's disease. Like a camel caravan carefully managing their supplies, we must recognize that maintaining optimal vitamin levels can play a crucial role in navigating the desert of Parkinson's disease.
Dr. Camel's Conclusion
This study provides a fascinating insight into the interplay between vitamin levels, homocysteine, and levodopa treatment in the context of Parkinson's disease. It serves as a reminder that, like a desert ecosystem, the human body is a complex and interconnected environment. Optimizing vitamin levels can potentially be a valuable tool in managing homocysteine levels and improving treatment outcomes for individuals navigating the desert of Parkinson's disease.
Date :
- Date Completed 2006-07-27
- Date Revised 2014-11-20
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.